{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:56:34Z","timestamp":1793642194193,"version":"4.5.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Congenital Heart Defects (CHD) is the most commonly occurring congenital anomaly in Europe and a major paediatric health care concern. Investigations are needed to enable identification of CHD risk factors as studies have given conflicting results. This study aim was to identify maternal sociodemographic characteristics, behaviours, and birth outcomes as risk factors for CHD. This was a population based, data linkage cohort study using anonymised data from Northern Ireland (NI) covering the period 2010-2014. The study cohort composed of 94,067 live births with an outcome of 1162 cases of CHD using the International Statistical Classification of Diseases and Related Health Problems (ICD)-10 codes and based on the European Surveillance of Congenital Anomalies (EUROCAT) grouping system for CHD. CHD cases were obtained from the HeartSuite database (HSD) at the Royal Belfast Hospital for Sick Children (RBHSC), maternal data were extracted from the Northern Ireland Maternity System (NIMATS), and medication data were extracted from the Enhanced Prescribing Database (EPD). STATA version 14 was used for the statistical analysis in this study, Odds Ratio (OR), 95% Confident intervals (CI), P value, and logistic regression were used in the analysis. Ethical approval was granted from the National Health Service (NHS) Research Ethics Committee.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>In this study, a number of potential risk factors were assessed for statistically significant association with CHD, however only certain risk factors demonstrated a statistically significant association with CHD which included: gestational age at first booking (AOR\u2009=\u20091.21; 95% CI\u2009=\u20091.04-1.41; P\u2009&lt;\u20090.05), family history of CHD or congenital abnormalities and syndromes (AOR\u2009=\u20094.14; 95% CI\u2009=\u20092.47-6.96; P\u2009&lt;\u20090.05), woman\u2019s smoking in pregnancy (AOR\u2009=\u20091.22; 95% CI\u2009=\u20091.04-1.43; P\u2009&lt;\u20090.05), preterm birth (AOR\u2009=\u20093.01; 95% CI\u2009=\u20092.44-3.01; P\u2009&lt;\u20090.05), multiple births (AOR\u2009=\u20091.89; 95% CI\u2009=\u20091.58-2.60; P\u2009&lt;\u20090.05), history of abortion (AOR\u2009=\u20091.12; 95% CI\u2009=\u20091.03-1.28; P\u2009&lt;\u20090.05), small for gestational age (SGA) (AOR\u2009=\u20091.44; 95% CI\u2009=\u20091.22-1.78; P\u2009&lt;\u20090.05), and low birth weight (LBW) (AOR\u2009=\u20093.10; 95% CI\u2009=\u20092.22-3.55; P\u2009&lt;\u20090.05). Prescriptions and redemptions of antidiabetic (AOR\u2009=\u20092.68; 95% CI\u2009=\u20091.85-3.98; P\u2009&lt;\u20090.05), antiepileptic (AOR\u2009=\u20091.77; 95% CI\u2009=\u20091.10-2.81; P\u2009&lt;\u20090.05), and dihydrofolate reductase inhibitors (DHFRI) (AOR\u2009=\u20092.13; 95% CI\u2009=\u20091.17-5.85; P\u2009&lt;\u20090.05) in early pregnancy also showed evidence of statistically significant association with CHD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this study suggested that there are certain maternal sociodemographic characteristics, behaviours and birth outcomes that are statistically significantly associated with higher risk of CHD. Appropriate prevention policy to target groups with higher risk for CHD may help to reduce CHD prevalence. These results are important for policy makers, obstetricians, cardiologists, paediatricians, midwives and the public.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12884-021-04223-4","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T09:02:32Z","timestamp":1636534952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Maternal sociodemographic characteristics, early pregnancy behaviours, and livebirth outcomes as congenital heart defects risk factors - Northern Ireland 2010-2014"],"prefix":"10.1186","volume":"21","author":[{"given":"Hafi","family":"Saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Bunting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"4223_CR1","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/pd.5148","volume":"37","author":"G Henk","year":"2017","unstructured":"Henk G, Katelijne B, Anna P, Judith R, Anke R, Martin H, et al. Stillbirth and neonatal mortality in pregnancies complicated by major congenital anomalies: Findings from a large European cohort. Prenat Diagn. 2017;37:1100\u201311.","journal-title":"Prenat Diagn"},{"key":"4223_CR2","first-page":"25","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","unstructured":"Centers for Disease Control and Prevention (CDC). Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects--United States, 2003. MMWR Morb Mortal Wkly Rep. 2007;56:25\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4223_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-3016.2008.00987.x","volume":"23","author":"P Dadvand","year":"2009","unstructured":"Dadvand P, Rankin J, Shirley MDF, Rushton S, Pless-Mulloli T. Descriptive epidemiology of congenital heart disease in Northern England. Paediatr Perinat Epidemiol. 2009;23:58\u201365.","journal-title":"Paediatr Perinat Epidemiol."},{"key":"4223_CR4","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.110.947002","volume":"122","author":"SM Gilboa","year":"2010","unstructured":"Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation. 2010;122:2254\u201363.","journal-title":"Circulation."},{"key":"4223_CR5","unstructured":"Dodge I. New Congenital Heart Disease Review [Internet]. NHS England; 2015 p. 27. Available from: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2015\/07\/Item-4-CHD-Report.pdf"},{"key":"4223_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/JCN.0000000000000466","volume":"33","author":"GMR Becky","year":"2018","unstructured":"Becky GMR, Prouhet PM, Russell CL, Pfannenstiel BR. Quality of Life for Parents of Children With Congenital Heart Defect: A Systematic Review. J Cardiovasc Nurs. 2018;33:363.","journal-title":"J Cardiovasc Nurs"},{"key":"4223_CR7","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIR.0b013e318265ee8a","volume":"126","author":"BS Marino","year":"2012","unstructured":"Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126:1143\u201372.","journal-title":"Circulation."},{"key":"4223_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13052-014-0085-3","volume":"40","author":"Y Feng","year":"2014","unstructured":"Feng Y, Yu D, Yang L, Da M, Wang Z, Lin Y, et al. Maternal lifestyle factors in pregnancy and congenital heart defects in offspring: review of the current evidence. Ital J Pediatr. 2014;40:85.","journal-title":"Ital J Pediatr."},{"key":"4223_CR9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00246-013-0775-4","volume":"34","author":"SS Patel","year":"2013","unstructured":"Patel SS, Burns TL. Nongenetic Risk Factors and Congenital Heart Defects. Pediatr Cardiol. 2013;34:1535\u201355.","journal-title":"Pediatr Cardiol."},{"key":"4223_CR10","unstructured":"Business Services Organisation. 2015. Honest Broker Service. Available from: http:\/\/www.hscbusiness.hscni.net\/services\/2454.htm. [Accessed 3 January 2015]."},{"issue":"1","key":"4223_CR11","first-page":"19","volume":"19","author":"H Saad","year":"2021","unstructured":"Saad H, Bunting B, Mc CJ. How can Big Data be used to answer public health research questions? Evid Based Midwifery. 2021;19(1):19\u201331.","journal-title":"Evid Based Midwifery"},{"key":"4223_CR12","unstructured":"EUROCAT Guide 1.4. 2013. Available from: http:\/\/www.eurocat-network.eu\/content\/Full%20Guide%201%204%20version%2021_June2018.pdf. [Accessed 10 December 2015]."},{"key":"4223_CR13","doi-asserted-by":"publisher","first-page":"h1798","DOI":"10.1136\/bmj.h1798","volume":"350","author":"K Furu","year":"2015","unstructured":"Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ. 2015;350:h1798.","journal-title":"BMJ."},{"key":"4223_CR14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","volume":"163","author":"KS Crider","year":"2009","unstructured":"Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med. 2009;163:978\u201385.","journal-title":"Arch Pediatr Adolesc Med."},{"key":"4223_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/CLEP.S9256","volume":"2","author":"JB Kornum","year":"2010","unstructured":"Kornum JB, Nielsen R. B., Pedersen L., Mortensen P. B., Norgaard M. Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: Updated analysis. Clin Epidemiol. 2010;2:29\u201336.","journal-title":"Clin Epidemiol"},{"key":"4223_CR16","doi-asserted-by":"crossref","unstructured":"Knudsen TM, Hansen AV, Garne E, Andersen AM. Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy\u2013an epidemiological study using validated EUROCAT data. BMC Pregnancy Childbirth. 2014;14(1):1\u20138.","DOI":"10.1186\/1471-2393-14-333"},{"key":"4223_CR17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00787-010-0087-7","volume":"19","author":"M Szumilas","year":"2010","unstructured":"Szumilas M. Explaining Odds Ratios. J Can Acad Child Adolesc Psychiatry. 2010;19:227\u20139.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"4223_CR18","unstructured":"Gordis L. Epidemiology, Fourth edition. Saunders; 2008. p. 208. https:\/\/www.pdf-archive.com\/2014\/09\/16\/leon-gordis-epidemiology-4th-uploadedby-arif-sobhan\/. Accessed 30 Jan 2017."},{"key":"4223_CR19","doi-asserted-by":"crossref","unstructured":"Ranganathan P, Aggarwal R, Pramesh CS. Common pitfalls in statistical analysis: Odds versus risk. Perspect Clin Res. 2015;6(4):222.","DOI":"10.4103\/2229-3485.167092"},{"key":"4223_CR20","volume-title":"Modern Epidemiology. Third ed","author":"KJ Rothman","year":"2008","unstructured":"Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Third ed. Philadelphia, USA: Lipincott Williams and Wilkins; 2008."},{"key":"4223_CR21","unstructured":"EBCOG Scientific Committee. The public health importance of antenatal care.\u00a0Facts Views Vision ObGyn.\u00a02015;7(1):5."},{"key":"4223_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2458-14-152","volume":"14","author":"L Wu","year":"2014","unstructured":"Wu L, Li B, Xia J, Ji C, Liang Z, Ma Y, et al. Prevalence of congenital heart defect in Guangdong province, 2008-2012. BMC Public Health. 2014;14:152.","journal-title":"BMC Public Health"},{"key":"4223_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1442-200X.2011.03341.x","volume":"53","author":"TD Zen","year":"2011","unstructured":"Zen TD, Rosa RFM, Zen PRG, Trevisan P, da Silva AP, Ricachinevsky CP, et al. Gestational and family risk factors for carriers of congenital heart defects in southern Brazil. Pediatr Int. 2011;53:551\u20137.","journal-title":"Pediatr Int"},{"key":"4223_CR24","volume-title":"Maternal Socioeconomic Status and the Risk of Congenital Heart Defects in Offspring: A Meta-Analysis of 33 Studies","author":"D Yu","year":"2014","unstructured":"Yu D, Feng Y, Yang L, Da M, Fan C, Wang S, et al. Maternal Socioeconomic Status and the Risk of Congenital Heart Defects in Offspring: A Meta-Analysis of 33 Studies. 2014;"},{"key":"4223_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108944","volume":"9","author":"Y Feng","year":"2014","unstructured":"Feng Y, Yu D, Chen T, Liu J, Tong X, Yang L, et al. Maternal parity and the risk of congenital heart defects in offspring: a dose-response meta-analysis of epidemiological observational studies. PLoS One. 2014;9:e108944.","journal-title":"PLoS One"},{"key":"4223_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/bdra.20065","volume":"70","author":"J Reefhuis","year":"2004","unstructured":"Reefhuis J, Honein MA. Maternal age and non-chromosomal birth defects, Atlanta\u20141968\u20132000: Teenager or thirty-something, who is at risk? Birth Defects Res Part A Clin Mol Teratol. 2004;70:572\u20139.","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"4223_CR27","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/ajmg.a.34130","volume":"155","author":"A Miller","year":"2011","unstructured":"Miller A, Tiffany R, Csaba S, Fr\u00edas Jaime L, Adolfo C. Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. Am J Med Genet A. 2011;155:2137\u201345.","journal-title":"Am J Med Genet A"},{"key":"4223_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/bdra.23507","volume":"106","author":"KE Best","year":"2016","unstructured":"Best KE, Rankin J. Is advanced maternal age a risk factor for congenital heart disease? Birth Defects Res Part A Clin MolTeratol. 2016;106:461\u20137.","journal-title":"Birth Defects Res Part A Clin MolTeratol"},{"key":"4223_CR29","doi-asserted-by":"publisher","first-page":"e810","DOI":"10.1542\/peds.2007-1519","volume":"121","author":"S Malik","year":"2008","unstructured":"Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, et al. Maternal smoking and congenital heart defects. Pediatrics. 2008;121:e810\u20136.","journal-title":"Pediatrics."},{"key":"4223_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00246-012-0470-x","volume":"34","author":"LJ Lee","year":"2013","unstructured":"Lee LJ, Lupo PJ. Maternal Smoking During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Metaanalysis. Pediatr Cardiol. 2013;34:398\u2013407.","journal-title":"Pediatr Cardiol."},{"key":"4223_CR31","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1542\/peds.2010-1399","volume":"127","author":"CJ Alverson","year":"2011","unstructured":"Alverson CJ, Strickland MJ, Gilboa SM, Correa A. Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics. 2011;127:e647\u201353.","journal-title":"Pediatrics."},{"key":"4223_CR32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/00001648-200109000-00007","volume":"12","author":"IALM van Rooij","year":"2001","unstructured":"van Rooij IALM, Wegerif MJM, Roelofs HMJ, Peters WHM, Kuijpers-Jagtman A-M, Zielhuis GA, et al. Smoking, Genetic Polymorphisms in Biotransformation Enzymes, and Nonsyndromic Oral Clefting: A Gene-Environment Interaction. Epidemiology. 2001;12:502\u20137.","journal-title":"Epidemiology."},{"key":"4223_CR33","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1289\/ehp.1104305","volume":"120","author":"PJ Lupo","year":"2012","unstructured":"Lupo PJ, Langlois PH, Reefhuis J, Lawson CC, Symanski E, Desrosiers TA, et al. Maternal Occupational Exposure to Polycyclic Aromatic Hydrocarbons: Effects on Gastroschisis among Offspring in the National Birth Defects Prevention Study. Environ Health Perspect. 2012;120:910\u20135.","journal-title":"Environ Health Perspect"},{"key":"4223_CR34","first-page":"94","volume":"46","author":"O Barbieri","year":"1986","unstructured":"Barbieri O, Ognio E, Rossi O, Astigiano S, Rossi L. Embryotoxicity of Benzo(a)pyrene and Some of Its Synthetic Derivatives in Swiss Mice. Cancer Res. 1986;46:94\u20138.","journal-title":"Cancer Res"},{"key":"4223_CR35","doi-asserted-by":"publisher","first-page":"H414","DOI":"10.1152\/ajpheart.00600.2013","volume":"306","author":"G Karunamuni","year":"2014","unstructured":"Karunamuni G, Gu S, Doughman YQ, Peterson LM, Mai K, McHale Q, et al. Ethanol exposure alters early cardiac function in the looping heart: a mechanism for congenital heart defects? Am J Physiol Heart Circ Physiol. 2014;306:H414\u201321.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4223_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13052-016-0222-2","volume":"42","author":"Z Wen","year":"2016","unstructured":"Wen Z, Yu D, Zhang W, Fan C, Hu L, Feng Y, et al. Association between alcohol consumption during pregnancy and risks of congenital heart defects in offspring: meta-analysis of epidemiological observational studies. Ital J Pediatr. 2016;42:12.","journal-title":"Ital J Pediatr"},{"key":"4223_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130681","volume":"10","author":"J Yang","year":"2015","unstructured":"Yang J, Qiu H, Qu P, Zhang R, Zeng L, Yan H. Prenatal Alcohol Exposure and Congenital Heart Defects: A Meta-Analysis. PLoS One. 2015;10:e0130681.","journal-title":"PLoS One"},{"key":"4223_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00246-014-1079-z","volume":"36","author":"Y Feng","year":"2015","unstructured":"Feng Y, Wang S, Zhao L, Yu D, Hu L, Mo X. Maternal reproductive history and the risk of congenital heart defects in offspring: a systematic review and meta-analysis. Pediatr Cardiol. 2015;36:253\u201363.","journal-title":"Pediatr Cardiol"},{"key":"4223_CR39","volume-title":"Abortion, substance abuse and mental health in early adulthood: Thirteen-year longitudinal evidence from the United States: SAGE Open Medicine","author":"DP Sullins","year":"2016","unstructured":"Sullins DP. Abortion, substance abuse and mental health in early adulthood: Thirteen-year longitudinal evidence from the United States: SAGE Open Medicine. London, England: SAGE PublicationsSage UK; 2016. Available from: https:\/\/journals.sagepub.com\/doi\/10.1177\/2050312116665997 [Accessed 3 June 2019]"},{"key":"4223_CR40","first-page":"e1225","volume":"131","author":"JL Zhu","year":"2013","unstructured":"Zhu JL, Olsen J, S\u00f8rensen HT, Li J, Nohr EA, Obel C, et al. Prenatal Maternal Bereavement and Congenital Heart Defects in Offspring: A Registry-Based Study. Pediatrics Am Acad Pediatrics. 2013;131:e1225\u201330.","journal-title":"Pediatrics Am Acad Pediatrics"},{"key":"4223_CR41","doi-asserted-by":"crossref","unstructured":"Li H, Luo M, Zheng J, Luo J, Zeng R, Feng N, et al. An artificial neural network prediction model of congenital heart disease based on risk factors. Medicine (Baltimore). 2017;96 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5313026\/. [cited 2020 Jun 3].","DOI":"10.1097\/MD.0000000000006090"},{"key":"4223_CR42","volume-title":"Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington Infant Study, 1981-1989","author":"C Ferencz","year":"1997","unstructured":"Ferencz C. Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington Infant Study, 1981-1989: Futura Publishing Company; 1997."},{"key":"4223_CR43","doi-asserted-by":"crossref","unstructured":"Fung A, Manlhiot C, Naik S, Rosenberg H, Smythe J, Lougheed J, Mondal T, Chitayat D, McCrindle BW, Mital S. Impact of prenatal risk factors on congenital heart disease in the current era. J Am Heart Assoc. 2013;2(3):e000064.","DOI":"10.1161\/JAHA.113.000064"},{"key":"4223_CR44","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJM200011303432204","volume":"343","author":"S Hern\u00e1ndez-D\u00edaz","year":"2000","unstructured":"Hern\u00e1ndez-D\u00edaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000;343:1608\u201314.","journal-title":"N Engl J Med."},{"key":"4223_CR45","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1365-2125.2009.03544.x","volume":"68","author":"I Matok","year":"2009","unstructured":"Matok I, Gorodischer R, Koren G, Landau D, Wiznitzer A, Levy A. Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations. Br J Clin Pharmacol. 2009;68:956\u201362.","journal-title":"Br J Clin Pharmacol."},{"key":"4223_CR46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.reprotox.2005.01.008","volume":"20","author":"WM Meijer","year":"2005","unstructured":"Meijer WM, De Walle HE, Kerstjens-Frederikse WS. Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists. Reprod Toxicol. 2005;20:203\u20137.","journal-title":"Reprod Toxicol"},{"key":"4223_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/dvdy.10469","volume":"229","author":"BJ Tierney","year":"2004","unstructured":"Tierney BJ, Ho T, Reedy MV, Brauer PR. Homocysteine inhibits cardiac neural crest cell formation and morphogenesis in vivo. Dev Dyn. 2004;229:63\u201373.","journal-title":"Dev Dyn"},{"key":"4223_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/dvdy.10303","volume":"227","author":"MJ Boot","year":"2003","unstructured":"Boot MJ, Steegers-Theunissen RPM, Poelmann RE, Van Iperen L, Lindemans J, Gittenberger-de Groot AC. Folic acid and homocysteine affect neural crest and neuroepithelial cell outgrowth and differentiation in vitro. Dev Dyn. 2003;227:301\u20138.","journal-title":"Dev Dyn"},{"key":"4223_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0140-6736(05)66239-3","volume":"350","author":"J Wild","year":"1997","unstructured":"Wild J, Sutcliffe M, Schorah CJ, Levene MI. Prevention of neural-tube defects. Lancet. 1997;350:30\u20131.","journal-title":"Lancet."},{"key":"4223_CR50","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/eurheartj\/ehi815","volume":"27","author":"IM van Beynum","year":"2006","unstructured":"van Beynum IM, Kapusta L, den Heijer M, Vermeulen SHHM, Kouwenberg M, Dani\u00ebls O, et al. Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J. 2006;27:981\u20137.","journal-title":"Eur Heart J"},{"key":"4223_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/bdra.20043","volume":"70","author":"LS Tang","year":"2004","unstructured":"Tang LS, Wlodarczyk BJ, Santillano DR, Miranda RC, Finnell RH. Developmental consequences of abnormal folate transport during murine heart morphogenesis. Birth Defects Res Part A Clin Mol Teratol. 2004;70:449\u201358.","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"4223_CR52","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0140-6736(13)62071-1","volume":"382","author":"K Wellings","year":"2013","unstructured":"Wellings K, Jones KG, Mercer CH, Tanton C, Clifton S, Datta J, et al. The prevalence of unplanned pregnancy and associated factors in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Lancet. 2013;382:1807\u201316.","journal-title":"Lancet."},{"key":"4223_CR53","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/01.AOG.0000255666.78427.c5","volume":"109","author":"AP Mohllajee","year":"2007","unstructured":"Mohllajee AP, Curtis KM, Morrow B, Marchbanks PA. Pregnancy Intention and Its Relationship to Birth and Maternal Outcomes. Obstet Gynecol. 2007;109:678.","journal-title":"Obstet Gynecol"},{"key":"4223_CR54","doi-asserted-by":"crossref","unstructured":"Feng Y, Wang S, Chen R, Tong X, Wu Z, Mo X. Maternal folic acid supplementation and the risk of congenital heart defects in offspring: a meta-analysis of epidemiological observational studies. Sci Rep. 2015;5(1):1\u20138.","DOI":"10.1038\/srep08506"},{"key":"4223_CR55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/ajcn\/81.1.147","volume":"81","author":"CA Hobbs","year":"2005","unstructured":"Hobbs CA, Cleves MA, Melnyk S, Zhao W, James SJ. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr. 2005;81:147\u201353.","journal-title":"Am J Clin Nutr"},{"key":"4223_CR56","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/oxfordjournals.aje.a010070","volume":"150","author":"MM Werler","year":"1999","unstructured":"Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA. Multivitamin supplementation and risk of birth defects. Am J Epidemiol. 1999;150:675\u201382.","journal-title":"Am J Epidemiol."},{"key":"4223_CR57","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1467-842X.2006.tb00867.x","volume":"30","author":"C Bower","year":"2006","unstructured":"Bower C, Miller M, Payne J, Serna P. Folate intake and the primary prevention of non-neural birth defects. Aust N Z J Public Health. 2006;30:258\u201361.","journal-title":"Aust N Z J Public Health"},{"key":"4223_CR58","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/jama.2009.113","volume":"301","author":"KJ Stothard","year":"2009","unstructured":"Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009;301:636\u201350.","journal-title":"JAMA."},{"key":"4223_CR59","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3945\/ajcn.2009.28865","volume":"91","author":"JL Mills","year":"2010","unstructured":"Mills JL, Troendle J, Conley MR, Carter T, Druschel CM. Maternal obesity and congenital heart defects: a population-based study. Am J Clin Nutr. 2010;91:1543\u20139.","journal-title":"Am J Clin Nutr"},{"key":"4223_CR60","first-page":"91","volume":"211","author":"G Cai","year":"2014","unstructured":"Cai G, Sun X, Zhang L, Hong Q. Association between maternal body mass index and congenital heart defects in offspring: a systematic review. Obstet Gynecol. 2014;211:91\u2013117.","journal-title":"Obstet Gynecol."},{"key":"4223_CR61","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/bdra.22886","volume":"94","author":"E Garne","year":"2012","unstructured":"Garne E, Loane M, Dolk H, Barisic I, Addor M-C, Arriola L, et al. Spectrum of congenital anomalies in pregnancies with pregestational diabetes. Birth Defects Res Part A Clin MolTeratol. 2012;94:134\u201340.","journal-title":"Birth Defects Res Part A Clin MolTeratol"},{"key":"4223_CR62","doi-asserted-by":"publisher","first-page":"e976","DOI":"10.1542\/peds.2006-2742","volume":"119","author":"S Malik","year":"2007","unstructured":"Malik S, Cleves MA, Zhao W, Correa A, Hobbs CA. Association Between Congenital Heart Defects and Small for Gestational Age. Pediatrics. 2007;119:e976\u201382.","journal-title":"Pediatrics."},{"issue":"11","key":"4223_CR63","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/pd.5770","volume":"40","author":"V Giorgione","year":"2020","unstructured":"Giorgione V, Fesslova V, Boveri S, Candiani M, Khalil A, Cavoretto P. Adverse perinatal outcome and placental abnormalities in pregnancies with major fetal congenital heart defects: A retrospective case-control study. Prenat Diagn. 2020;40(11):1390\u20137.","journal-title":"Prenat Diagn"},{"key":"4223_CR64","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1136\/heartjnl-2015-307826","volume":"101","author":"KE Best","year":"2015","unstructured":"Best KE, Rankin J. Increased risk of congenital heart disease in twins in the North of England between 1998 and 2010. Heart. 2015;101:1807\u201312.","journal-title":"Heart."},{"key":"4223_CR65","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1017\/S1047951114001644","volume":"25","author":"RA Petrossian","year":"2015","unstructured":"Petrossian RA, Kuehl KS, Loffredo CA. Relationship of birth weight with congenital cardiovascular malformations in a population-based study. Cardiol Young. 2015;25:1086\u201392.","journal-title":"Cardiol Young"},{"key":"4223_CR66","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1542\/peds.2005-0397","volume":"116","author":"K Tanner","year":"2005","unstructured":"Tanner K, Sabrine N, Wren C. Cardiovascular malformations among preterm infants. Pediatrics. 2005;116:e833\u20138.","journal-title":"Pediatrics."},{"key":"4223_CR67","doi-asserted-by":"publisher","first-page":"e829","DOI":"10.1542\/peds.2011-3279","volume":"130","author":"E Laas","year":"2012","unstructured":"Laas E, Lelong N, Thieulin A-C, Houyel L, Bonnet D, Ancel P-Y, et al. Preterm birth and congenital heart defects: a population-based study. Pediatrics. 2012;130:e829\u201337.","journal-title":"Pediatrics."},{"key":"4223_CR68","first-page":"663","volume":"107","author":"JW Dudenhausen","year":"2010","unstructured":"Dudenhausen JW, Maier RF. Perinatal Problems in Multiple Births. Dtsch Arztebl Int. 2010;107:663\u20138.","journal-title":"Dtsch Arztebl Int"},{"key":"4223_CR69","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1053\/j.semperi.2015.03.007","volume":"39","author":"RS Olney","year":"2015","unstructured":"Olney RS, Ailes EC, Sontag MK. Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening. Semin Perinatol. 2015;39:230\u20137.","journal-title":"Semin Perinatol"},{"key":"4223_CR70","doi-asserted-by":"crossref","unstructured":"Amel-Shahbaz S, Behjati-Ardakani M, Namayandeh SM, Vafaeenasab M, Andishmand A, Moghimi S, et al. The epidemiological aspects of congenital heart disease in central and southern district of Iran. Adv Biomed Res. 2014;3 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4260289\/ [Accessed 2 September 2016].","DOI":"10.4103\/2277-9175.145732"},{"key":"4223_CR71","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/tera.1051","volume":"64","author":"CA Loffredo","year":"2001","unstructured":"Loffredo CA, Wilson PD, Ferencz C. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology. 2001;64:98\u2013106.","journal-title":"Teratology."},{"key":"4223_CR72","first-page":"237","volume":"199","author":"A Correa","year":"2008","unstructured":"Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, et al. Diabetes mellitus and birth defects. Obstet Gynecol. 2008;199:237 e1-237. e9.","journal-title":"Obstet Gynecol"},{"key":"4223_CR73","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.115.017465","volume":"133","author":"N \u00d8yen","year":"2016","unstructured":"\u00d8yen N, Diaz LJ, Leirgul E, Boyd HA, Priest J, Mathiesen ER, et al. Prepregnancy Diabetes and Offspring Risk of Congenital Heart Disease. Circulation. 2016;133:2243\u201353.","journal-title":"Circulation."},{"issue":"6","key":"4223_CR74","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00404-019-05376-6","volume":"300","author":"L Chen","year":"2019","unstructured":"Chen L, Yang T, Chen L, Wang L, Wang T, Zhao L, et al. Risk of congenital heart defects in offspring exposed to maternal diabetes mellitus: an updated systematic review and meta-analysis. Arch Gynecol Obstet. 2019;300(6):1491\u2013506.","journal-title":"Arch Gynecol Obstet"},{"key":"4223_CR75","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/00003081-199134030-00002","volume":"34","author":"L Cousins","year":"1991","unstructured":"Cousins L. Etiology and prevention of congenital anomalies among infants of overt diabetic women. Clin Obstet Gynecol. 1991;34:481\u201393.","journal-title":"Clin Obstet Gynecol"},{"key":"4223_CR76","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/bdra.20807","volume":"91","author":"JM Salbaum","year":"2011","unstructured":"Salbaum JM, Kappen C. Diabetic embryopathy: a role for the epigenome? Birth Defects Res Part A Clin Mol Teratol. 2011;91:770\u201380.","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"4223_CR77","doi-asserted-by":"crossref","unstructured":"Ludvigsson JF, Neovius M, S\u00f6derling J, Gudbj\u00f6rnsdottir S, Svensson AM, Franz\u00e9n S, Stephansson O, Pasternak B. Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden. BMJ. 2018;362.","DOI":"10.1136\/bmj.k2638"},{"issue":"18","key":"4223_CR78","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1001\/jama.2019.4981","volume":"321","author":"AS Alexopoulos","year":"2019","unstructured":"Alexopoulos AS, Blair R, Peters AL. Management of Preexisting Diabetes in Pregnancy: A Review. JAMA. 2019;321(18):1811\u20139.","journal-title":"JAMA."},{"issue":"Suppl 1","key":"4223_CR79","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.2337\/dc19-S014","volume":"42","author":"A American Diabetes","year":"2019","unstructured":"American Diabetes A. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S165\u201372.","journal-title":"Diabetes Care"},{"key":"4223_CR80","first-page":"361","volume":"25","author":"JE Given","year":"2018","unstructured":"Given JE, Loane M, Garne E, Addor MC, Bakker M, Bertaut-Nativel B, et al. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ. 2018;25:361.","journal-title":"BMJ"},{"issue":"5","key":"4223_CR81","doi-asserted-by":"publisher","first-page":"e0155737","DOI":"10.1371\/journal.pone.0155737","volume":"11","author":"RA Charlton","year":"2016","unstructured":"Charlton RA, Klungs\u00f8yr K, Neville AJ, Jordan S, Pierini A, de Jong-van den Berg LTW, et al. Prescribing of Antidiabetic Medicines before, during and after Pregnancy: A Study in Seven European Regions. PLoS One. 2016;11(5):e0155737 4.","journal-title":"PLoS One"},{"issue":"1","key":"4223_CR82","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/AOG.0b013e318278ce86","volume":"121","author":"JM Lawrence","year":"2013","unstructured":"Lawrence JM, Andrade SE, Avalos LA, Beaton SJ, Chiu VY, Davis RL. Prevalence, trends and patterns of use of antidiabetic medications among pregnant women 2001\u20132007. Obstet Gynecol. 2013;121(1):106\u201314. 23262934.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"4223_CR83","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/pds.3511","volume":"22","author":"TA Hammad","year":"2013","unstructured":"Hammad TA, Margulis AV, Ding Y, Strazzeri MM, Epperly H. Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink. Pharmacoepidemiol Drug Saf. 2013;22(11):1233\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"4223_CR84","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/pds.1431","volume":"16","author":"KE Wurst","year":"2007","unstructured":"Wurst KE, Ephross SA, Loehr J, Clark DW, Guess HA. The utility of the general practice research database to examine selected congenital heart defects: a validation study. Pharmacoepidemiol Drug Saf. 2007;16(8):867\u201377.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4223_CR85","first-page":"108","volume":"35","author":"M Cs\u00e1ky-Szunyogh","year":"2014","unstructured":"Cs\u00e1ky-Szunyogh M, Vereczkey A, K\u00f3sa Z, Gerencs\u00e9r B, Czeizel AE. Risk Factors in the Origin of Congenital Left-Ventricular Outflow-Tract Obstruction Defects of the Heart: A Population-Based Case\u2013Control Study. PediatrCardiol. 2014;35:108\u201320.","journal-title":"PediatrCardiol."},{"key":"4223_CR86","unstructured":"Department of Health, Social Services and Public Safety. 2016. Available from: https:\/\/www.health-ni.gov.uk\/sites\/default\/files\/publications\/dhssps\/guidance-termination-pregnancy.pdf. [Accessed 3 January 2016]."},{"key":"4223_CR87","unstructured":"Torney K. Belfast based journalism project. The Irish Times 2015. Available from: https:\/\/www.irishtimes.com\/news\/health\/nearly-25-000-irish-women-went-to-britain-for-abortions-in-2010-2014-1.2465367. [Accessed 25 July 2016]."},{"key":"4223_CR88","doi-asserted-by":"crossref","unstructured":"Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. Jama. 2011;306(22):2459.","DOI":"10.1001\/jama.2011.1823"},{"key":"4223_CR89","unstructured":"Scottish Perinatal and Infant Mortality and Morbidity Report. Healthcare Improvement Scotland; 2013. Available from: https:\/\/www.isdscotland.org\/Health-Topics\/Maternity-and-Births\/Publications\/2013-03-26\/2013-03-26-SPIMMR2011-report.pdf?207155943. Accessed 29 June 2019."},{"key":"4223_CR90","unstructured":"Royal College of Obstetricians and Gynaecologists. Diagnosis and Management of Ectopic Pregnancy. Royal College of Obstetricians & Gynaecologists. 2018. Available from: https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/gtg21\/ [Accessed 13 Mar 2018]."},{"key":"4223_CR91","unstructured":"Tommy\u2019s. 2018. Available from: https:\/\/www.tommys.org\/our-organisation\/charity-research\/pregnancy-statistics\/miscarriage. [Accessed 1 December 2018]."},{"key":"4223_CR92","doi-asserted-by":"publisher","first-page":"b4347","DOI":"10.1136\/bmj.b4347","volume":"339","author":"D Shipton","year":"2009","unstructured":"Shipton D, Tappin DM, Vadiveloo T, Crossley JA, Aitken DA, Chalmers J. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. BMJ. 2009;339:b4347.","journal-title":"BMJ."},{"issue":"6","key":"4223_CR93","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/archdischild-2016-311143","volume":"102","author":"RL Knowles","year":"2017","unstructured":"Knowles RL, Ridout D, Crowe S, Bull C, Wray J, Tregay J, et al. Ethnic and socioeconomic variation in incidence of congenital heart defects. Arch Dis Child. 2017;102(6):496\u2013502.","journal-title":"Arch Dis Child"},{"key":"4223_CR94","doi-asserted-by":"publisher","first-page":"126668","DOI":"10.1016\/j.chemosphere.2020.126668","volume":"253","author":"CY Hu","year":"2020","unstructured":"Hu CY, Huang K, Fang Y, Yang XJ, Ding K, Jiang W, et al. Maternal air pollution exposure and congenital heart defects in offspring: a systematic review and meta-analysis. Chemosphere. 2020;253:126668.","journal-title":"Chemosphere"},{"issue":"1","key":"4223_CR95","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/uog.18932","volume":"51","author":"V Giorgione","year":"2018","unstructured":"Giorgione V, Parazzini F, Fesslova VL, Cipriani SO, Candiani M, Inversetti AN, et al. Congenital heart defects in IVF\/ICSI pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(1):33\u201342.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"4223_CR96","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.116.024600","volume":"136","author":"HA Boyd","year":"2017","unstructured":"Boyd HA, Basit S, Behrens I, Leirgul E, Bundgaard H, Wohlfahrt J, et al. Association between fetal congenital heart defects and maternal risk of hypertensive disorders of pregnancy in the same pregnancy and across pregnancies. Circulation. 2017;136(1):39\u201348.","journal-title":"Circulation"},{"key":"4223_CR97","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/ajmg.a.36118","volume":"161","author":"M Csaky-Szunyogh","year":"2013","unstructured":"Csaky-Szunyogh M, Vereczkey A, Kosa Z, Gerencser B, Czeizel AE. Risk and protective factors in the origin of conotruncal defects of heart--a population-based case-control study. Am J Med GeneticsPart A. 2013;161:2444\u201352.","journal-title":"Am J Med GeneticsPart A"},{"key":"4223_CR98","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00228-011-1021-8","volume":"67","author":"B K\u00e4ll\u00e9n","year":"2011","unstructured":"K\u00e4ll\u00e9n B, Nilsson E, Olausson PO. Antidepressant use during pregnancy: comparison of data obtained from a prescription register and from antenatal care records. Eur J Clin Pharmacol. 2011;67:839\u201345.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04223-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04223-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04223-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T12:46:09Z","timestamp":1699793169000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04223-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["4223"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04223-4","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"24 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study\/methods\/data collection and analysis were carried out in accordance with relevant guidelines and regulations mainly Declaration of Helsinki, Good Clinical Practice guidelines, General Data Protection Regulation, and Data Protection Act.Ethical approval including consent waiver was granted from the Institute of Nursing and Health Research Governance Filter Committee, Ulster University (22 June 2015) and from National Health Service (NHS) Research Ethics Committee (NHS-REC) (No. 17\/SC\/0103, 27 February 2017). Honest Broker Governance Board approval was granted on 2 March 2017.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study is based on anonymised secondary data and no identifiable or individual data are published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests for any authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"759"}}